Blood tests may unlock secrets of rare brain disorders
NCT ID NCT04925349
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study collects blood samples from 100 people with rare brain diseases like adrenoleukodystrophy and metachromatic leukodystrophy. Researchers will study immune cells called macrophages to see if they affect how the disease progresses. No treatment is given; the goal is to learn more about these conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENOLEUKODYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Hôpital Bicêtre
RECRUITINGLe Kremlin-Bicêtre, 94275, France
-
AP-HP Hôpital La Pitié Salpêtrière
RECRUITINGParis, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Newborn screening study aims to catch rare diseases at birth
- New registry aims to unlock secrets of rare brain disease ALD
- Experimental enzyme therapy tested in rare brain disease after transplant
- Gene therapy shows promise for rare fatal brain disease in kids
- Restless leg drug tested for rare disease in women
- New stem cell approach aims to tame rare genetic diseases